Navigation Links
Experimental Drug Seems to Aid Memory in Mice With Alzheimer's
Date:5/14/2013

TUESDAY, May 14 (HealthDay News) -- An experimental drug improved the memory and brain function in older mice with advanced symptoms of Alzheimer's disease, according to a new study.

Researchers from the Salk Institute in San Diego found that the drug, known as J147, increased levels of proteins that form the connections responsible for learning and memory, and reduced levels of a protein linked to cell death in the mice.

This explains how treating the mice with J147 led to an increase in factors that are necessary for correct memory function, according to the authors of the study, which was published online May 13 in the journal Alzheimer's Research & Therapy.

The effectiveness of J147 is the result of a new drug-discovery approach developed at the Salk Institute, said David Schubert, who heads the Cellular Neurobiology Laboratory.

"Our approach to screening drugs is very different from that currently used by pharmaceutical companies," Schubert said in a journal news release. "Alzheimer's disease is a complex disease associated with old age, and our goal is to make drugs like J147 that reduce the multiple toxicities associated with the disease, not just one.

"We believe that J147 is the best Alzheimer's disease drug candidate in the pipeline and will be effective if we can get it into the clinic," he added.

The researchers noted that separate studies found that J147 and another drug called donepezil (brand name Aricept) improved short-term memory and another form of memory commonly lost in Alzheimer's patients. They said that only J147 improved spatial memory, which relates to remembering information about places, such as knowing your way around your neighborhood.

Success in animal research is no guarantee of similar results in human research.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.

-- Mary Elizabeth Dallas

SOURCE: BioMed Central, news release, May 13, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mayo Clinic finds experimental drug inhibits growth in all stages of common kidney cancer
2. Experimental Drug for Hepatitis C Promising, Studies Show
3. Experimental Vaccine Shows Promise for Ovarian Cancer
4. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
5. Experimental Staph Vaccine Fails to Work, Study Finds
6. Experimental Drug May Work Against Hepatitis C
7. Experimental Alzheimers Drug Shows Promise, Study Finds
8. Experimental Vitiligo Treatment Shows Promise in Mice
9. Harmful effects of bisphenol A proved experimentally
10. Experimental agent briefly eases depression rapidly in test
11. NIH-funded trial launched to assess experimental TB drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Drug Seems to Aid Memory in Mice With Alzheimer's
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology: